Assessment of bioequivalence using a multiplicative model
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 1 (2), 193-203
- https://doi.org/10.1080/10543409108835018
Abstract
In many bioavailability / bioequivalence studies, the distributions of responses such as AUC and Cmax are often positively skewed and exhibit a lack of homogeneity of variances. In this situation, a logarithmic transformation is usually consideredfor reduction of skew-ness and achievement of an additive model with relatively homogeneous variance. In this paper, consideration is given to a multiplicative model based on empirical evidence. A method is proposed using individual subject ratios for assessing the bioequivalence of two different formulations. This method is then subsequently extended to several commonly used crossover experiments.Keywords
This publication has 4 references indexed in Scilit:
- An Alternative Approach for the Assessment of Bioequivalence Between Two Formulations of a DrugBiometrical Journal, 1990
- Generalization of distribution – Free confidence intervals for bioavailability ratiosEuropean Journal of Clinical Pharmacology, 1985
- Statistical Methods for Bioavailability and BioequivalenceClinical Research Practices and Drug Regulatory Affairs, 1983
- An analysis of variance test for normality (complete samples)Biometrika, 1965